Table 2.
Mean lesion scores in the field efficacy trial of antimange agents in Central Kenya.
| Group | Lesion scores during treatment | ||||||
|---|---|---|---|---|---|---|---|
| Day 0 | Day 3 | Day 9 | Day 15 | Day 21 | Day 28 | Day 56 | |
| Ivermectin | 2.17 ± 0.15 | 1.57 ± 0.13 | 1.09 ± 0.12 | 0.71 ± 0.11 | 0.50 ± 0.11 | 0.24 ± 0.09 | 0.13 ± 0.05 |
| Liquid paraffin | 1.89 ± 0.12 | 1.09 ± 0.10 | 0.54 ± 0.10 | 0.27 ± 0.10 | 0.11 ± 0.06 | 0.03 ± 0.03 | 0.20 ± 0.12 |
| Carbaryl | 2.0 ± 0.13 | 1.286 ± 0.097 | 0.74 ± 0.10 | 0.50 ± 0.10 | 0.31 ± 0.09 | 0.23 ± 0.083 | 1.17 ± 0.06 |
| X 2(2) | 0.69 | 0.328 | 3.153 | 2.189 | 2.608 | 0.680 | 0.913 |
| p value | 0.709 | 0.849 | 0.207 | 0.335 | 0.271 | 0.712 | 0.634 |
A total of 29 rabbits per treatment group were scored for psoroptic mange lesions using criteria described by Pan et al. [26]. Kruskal–Wallis one-way analysis of variance in SPSS was conducted to examine the difference in lesion scores depending on test compounds administered.